Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide Farhat Nasim10 Aug 2019 4:51 PM ISTNEW DELHI: In a bid to re-enter the market with advanced drug-eluting stents (DES), various medical device makers are in talks with the Government to...
Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids; Farhat Nasim7 Aug 2019 5:30 PM ISTNew Delhi: After fixing the prices of various stents including cardiac stents and orthopaedic implants and even cancer drugs, the government is soon...
Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft Farhat Nasim28 Jun 2019 4:44 PM ISTNew Delhi: Through a recent draft Gazette notification, the Ministry of Health and Family Welfare has informed that not just drugmakers but drug...
More than 10 percent of Drug samples from Government sources Not of Standard Quality Meghna A Singhania25 Jun 2019 3:43 PM ISTNew Delhi: Estimated 10.02% medicines of the sample of medicines from government sources tested by the government were found to be Not of Standard...
Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names Farhat Nasim17 May 2019 5:37 PM ISTNew Delhi: In a major setback to many pharma companies in the country, the ruling Government is reported to have directed state drug controllers to...
China war on healthcare costs lure Indian drugmaker Sun Pharma: Report Medical Dialogues Bureau6 May 2019 9:15 AM ISTChina has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs Ruby Khatun Khatun8 Sept 2018 6:13 PM ISTThe 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D-Cold Tablet, Alkem's Sumo, Franco-Indian...
Dabur sues government for denied tax sops under GST Ruby Khatun Khatun23 Jun 2018 11:48 PM ISTMUMBAI: Central and Uttarakhand government have been dragged to court by Dabur for rejecting tax sops for investment in poorer areas promised under...
Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways Ruby Khatun Khatun18 March 2018 3:51 PM ISTNew Delhi: To provide their Multidrug-Resistant (MDR) TB drugs at cheaper rates to TB patients in India so that patients could easily access to them...
Allocate more funds, increase expenditure: Health experts Ruby Khatun Khatun23 Jan 2018 10:00 AM ISTNew Delhi: With the Union Budget around the corner, two health experts have urged the government to allocate more funds to sectors such as family...
Pharma giant Teva resists Israel PM on closure plan Ruby Khatun Khatun21 Dec 2017 9:30 AM ISTJerusalem: Teva, the world's largest generic drug company, refused Tuesday to reconsider a decision to close its Jerusalem plant despite pressure from...
1,179 Ayush drug manufacturers not compliant with Good Manufacturing Practices: Govt Ruby Khatun Khatun20 Dec 2017 3:58 PM ISTNew Delhi: There are 8,667 licenced Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) drug manufacturers in the country, out of which 1,179 are...
